CY1121556T1 - Διαδικασια για την παρασκευη ρυθμιστων του η3 υποδοχεα ισταμινης - Google Patents
Διαδικασια για την παρασκευη ρυθμιστων του η3 υποδοχεα ισταμινηςInfo
- Publication number
- CY1121556T1 CY1121556T1 CY20191100292T CY191100292T CY1121556T1 CY 1121556 T1 CY1121556 T1 CY 1121556T1 CY 20191100292 T CY20191100292 T CY 20191100292T CY 191100292 T CY191100292 T CY 191100292T CY 1121556 T1 CY1121556 T1 CY 1121556T1
- Authority
- CY
- Cyprus
- Prior art keywords
- histamine
- regulators
- concept
- procedure
- manufacture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Η παρούσα εφεύρεση εστιάζεται σε νέες διαδικασίες για την παρασκευή ρυθμιστών του Η3 υποδοχέα ισταμίνης, στην αντιμετώπιση για παράδειγμα, γνωστικών διαταραχών, διαταραχών του ύπνου και/ή ψυχιατρικών διαταραχών.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16117709P | 2009-03-18 | 2009-03-18 | |
| PCT/US2010/027638 WO2010107897A2 (en) | 2009-03-18 | 2010-03-17 | Process for the preparation of histamine h3 receptor modulators |
| EP10722449.5A EP2429996B1 (en) | 2009-03-18 | 2010-03-17 | Process for the preparation of histamine h3 receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1121556T1 true CY1121556T1 (el) | 2020-05-29 |
Family
ID=42315639
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20171100547T CY1119437T1 (el) | 2009-03-18 | 2017-05-26 | Διαδικασια για την παρασκευη ρυθμιστων του η3 υποδοχεα ισταμινης |
| CY20191100292T CY1121556T1 (el) | 2009-03-18 | 2019-03-12 | Διαδικασια για την παρασκευη ρυθμιστων του η3 υποδοχεα ισταμινης |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20171100547T CY1119437T1 (el) | 2009-03-18 | 2017-05-26 | Διαδικασια για την παρασκευη ρυθμιστων του η3 υποδοχεα ισταμινης |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US8748596B2 (el) |
| EP (3) | EP3216784B1 (el) |
| JP (1) | JP5642149B2 (el) |
| CN (1) | CN102428070B (el) |
| AU (1) | AU2010226711B2 (el) |
| CA (2) | CA2965059C (el) |
| CY (2) | CY1119437T1 (el) |
| DK (2) | DK2429996T3 (el) |
| ES (2) | ES2625261T3 (el) |
| HR (2) | HRP20170776T1 (el) |
| HU (2) | HUE032345T2 (el) |
| LT (2) | LT3216784T (el) |
| MX (3) | MX2011009784A (el) |
| PL (2) | PL3216784T3 (el) |
| PT (2) | PT2429996T (el) |
| SI (2) | SI3216784T1 (el) |
| TR (1) | TR201902858T4 (el) |
| WO (1) | WO2010107897A2 (el) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2625261T3 (es) | 2009-03-18 | 2017-07-19 | Janssen Pharmaceutica, N.V. | Procedimiento para la preparación de moduladores de receptores H3 de histamina |
| KR101427221B1 (ko) * | 2012-08-29 | 2014-08-13 | 주식회사 에스텍파마 | 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법 |
| CN104447867B (zh) * | 2013-09-17 | 2017-12-26 | 江苏天士力帝益药业有限公司 | 一种噻吩并哌啶衍生物、制备方法及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5724346B2 (el) * | 1973-06-22 | 1982-05-24 | ||
| PL215454B1 (pl) * | 2002-10-23 | 2013-12-31 | Janssen Pharmaceutica Nv | Pochodne piperazynylobenzamidu, ich zastosowanie oraz kompozycja farmaceutyczna je zawierajaca |
| US7777031B2 (en) | 2006-05-30 | 2010-08-17 | Janssen Pharmaceutica Nv | Substituted pyridyl amide compounds as modulators of the histamine H3 receptor |
| BRPI0820481A2 (pt) | 2007-11-20 | 2015-06-16 | Janssen Pharmaceutica Nv | Composotos cicloalquilóxi e heterocicloalquilóxi piridina como moduladores do receptor de h3 de histamina |
| ES2625261T3 (es) | 2009-03-18 | 2017-07-19 | Janssen Pharmaceutica, N.V. | Procedimiento para la preparación de moduladores de receptores H3 de histamina |
-
2010
- 2010-03-17 ES ES10722449.5T patent/ES2625261T3/es active Active
- 2010-03-17 PT PT107224495T patent/PT2429996T/pt unknown
- 2010-03-17 AU AU2010226711A patent/AU2010226711B2/en not_active Ceased
- 2010-03-17 EP EP17151754.3A patent/EP3216784B1/en active Active
- 2010-03-17 US US13/257,224 patent/US8748596B2/en active Active
- 2010-03-17 LT LTEP17151754.3T patent/LT3216784T/lt unknown
- 2010-03-17 DK DK10722449.5T patent/DK2429996T3/da active
- 2010-03-17 EP EP10722449.5A patent/EP2429996B1/en active Active
- 2010-03-17 PT PT17151754T patent/PT3216784T/pt unknown
- 2010-03-17 MX MX2011009784A patent/MX2011009784A/es active IP Right Grant
- 2010-03-17 LT LTEP10722449.5T patent/LT2429996T/lt unknown
- 2010-03-17 HU HUE10722449A patent/HUE032345T2/en unknown
- 2010-03-17 PL PL17151754T patent/PL3216784T3/pl unknown
- 2010-03-17 JP JP2012500921A patent/JP5642149B2/ja active Active
- 2010-03-17 SI SI201031867T patent/SI3216784T1/sl unknown
- 2010-03-17 SI SI201031474T patent/SI2429996T1/sl unknown
- 2010-03-17 MX MX2016007228A patent/MX349489B/es unknown
- 2010-03-17 CN CN201080022339.1A patent/CN102428070B/zh active Active
- 2010-03-17 EP EP18194673.2A patent/EP3492451B1/en active Active
- 2010-03-17 WO PCT/US2010/027638 patent/WO2010107897A2/en active Application Filing
- 2010-03-17 ES ES17151754T patent/ES2714852T3/es active Active
- 2010-03-17 CA CA2965059A patent/CA2965059C/en active Active
- 2010-03-17 TR TR2019/02858T patent/TR201902858T4/tr unknown
- 2010-03-17 PL PL10722449T patent/PL2429996T3/pl unknown
- 2010-03-17 CA CA2755335A patent/CA2755335C/en active Active
- 2010-03-17 MX MX2014015305A patent/MX347775B/es unknown
- 2010-03-17 HU HUE17151754 patent/HUE044837T2/hu unknown
- 2010-03-17 DK DK17151754.3T patent/DK3216784T3/en active
-
2014
- 2014-04-25 US US14/261,713 patent/US9518021B2/en active Active
-
2016
- 2016-11-11 US US15/349,521 patent/US9809547B2/en active Active
-
2017
- 2017-05-24 HR HRP20170776TT patent/HRP20170776T1/hr unknown
- 2017-05-26 CY CY20171100547T patent/CY1119437T1/el unknown
- 2017-10-04 US US15/724,711 patent/US10323002B2/en active Active
-
2019
- 2019-03-11 HR HRP20190476TT patent/HRP20190476T1/hr unknown
- 2019-03-12 CY CY20191100292T patent/CY1121556T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124729T1 (el) | Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου | |
| CY1123051T1 (el) | Ταπενταδολη για προληψη και θεραπεια καταθλιψης και αγχους | |
| CY1124144T1 (el) | Συνθεσεις και μεθοδοι για θεραπεια εγκεφαλικου επεισοδιου σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης | |
| CY1118249T1 (el) | Θεραπευτικες ενωσεις και συναφεις μεθοδοι χρησης | |
| CY1119766T1 (el) | Νεοι ρυθμιστες κινασης βενζοπυρανιου | |
| CY1122988T1 (el) | Υπογλωσσια υμενια | |
| CY1124918T1 (el) | Ρυθμιστες ccr2 | |
| CY1123746T1 (el) | Ανθρωποποιημενα tau αντισωματα σε νοσο του alzheimer | |
| CY1120297T1 (el) | Ρυθμιστες υποδοχεα ανδρογονου και χρησεις αυτων | |
| CY1122480T1 (el) | Μεθυλικη βαρδοξολονη για τη θεραπεια παχυσαρκιας | |
| CY1119840T1 (el) | Δικυκλικως υποκατεστημενες ουρακιλες και η χρηση αυτων | |
| PH12019501095A1 (en) | (aza)indole-,benzothiopene-, and benzofuran-3-sulfonamides | |
| PH12019500095A1 (en) | Compounds, compositions, and methods for the treatment of disease | |
| CR20140529A (es) | Anticuerpos e inmunoconjugados contra ly6e y métodos de uso | |
| PH12015502788A1 (en) | Antibody formulations and methods | |
| CY1121556T1 (el) | Διαδικασια για την παρασκευη ρυθμιστων του η3 υποδοχεα ισταμινης | |
| EA200971077A1 (ru) | Гетероциклические модуляторы киназы | |
| CL2008001705A1 (es) | Compuestos derivados de heterociclos de nitrogeno; y uso del compuesto para el tratamiento de enfermedades o trastornos relacionados con el receptor de histamina h3. | |
| EA201171063A1 (ru) | Фармацевтические составы олмесартана | |
| CY1121806T1 (el) | Ιμιδαζοπυραζινονες ως αναστολεις pde1 | |
| MX2022002954A (es) | Anticuerpos anti-htra1 y metodos de uso de los mismos. | |
| CR20160270A (es) | ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN | |
| EA201791508A1 (ru) | Способы трансдифференцировки и способы их использования | |
| AU2018348359A8 (en) | Extended release pharmaceutical formulation and methods of treatment | |
| EA201170699A1 (ru) | Тетразамещенные пиридазины в качестве антагонистов пути hedgehog |